AtriCure (ATRC) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $147.9 million.
- AtriCure's Cash & Current Investments rose 1345.0% to $147.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.9 million, marking a year-over-year increase of 1345.0%. This contributed to the annual value of $122.7 million for FY2024, which is 1060.86% down from last year.
- AtriCure's Cash & Current Investments amounted to $147.9 million in Q3 2025, which was up 1345.0% from $117.8 million recorded in Q2 2025.
- AtriCure's 5-year Cash & Current Investments high stood at $227.2 million for Q1 2021, and its period low was $99.9 million during Q1 2025.
- In the last 5 years, AtriCure's Cash & Current Investments had a median value of $122.6 million in 2022 and averaged $130.1 million.
- Data for AtriCure's Cash & Current Investments shows a peak YoY increase of 23150.71% (in 2021) and a maximum YoY decrease of 5123.62% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows AtriCure's Cash & Current Investments stood at $119.1 million in 2021, then grew by 1.7% to $121.1 million in 2022, then grew by 13.35% to $137.3 million in 2023, then fell by 10.61% to $122.7 million in 2024, then increased by 20.49% to $147.9 million in 2025.
- Its Cash & Current Investments stands at $147.9 million for Q3 2025, versus $117.8 million for Q2 2025 and $99.9 million for Q1 2025.